AlphaYouDR
Insider selling
David Raben sold $126K of Bicara Therapeutics Inc. (BCAX) stock
David Raben, Chief Medical Officer of Bicara Therapeutics Inc. (BCAX), sold 5,500 shares of BCAX stock worth $126K, per an SEC Form 4 filed Apr 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 27, 2026, 1 day before it was made public.
BCAX has moved -2.1% since the trade date, from $22.48 to $22.01 (Sep 21, 2026 close).
- Traded
- Apr 27, 2026
- Disclosed
- Apr 28, 2026
- Filing delay
- 1 day
- Price since
- -2.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More BCAX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.